Knee Bracing for People With Patellofemoral Osteoarthritis
Bracing in Patellofemoral Osteoarthritis: A Clinical Trial
3 other identifiers
interventional
80
1 country
2
Brief Summary
Osteoarthritis, sometimes called degenerative joint disease, is the most common form of arthritis. It occurs when the cartilage in joints wears down over time. Symptoms can include pain, tenderness, stiffness, and inflammation. Studies have suggested that symptoms of knee osteoarthritis may be caused by abnormalities at the patellofemoral joint, which is the joint between the kneecap, called the patella, and the thigh bone, called the femur. This study will determine whether wearing a knee brace that realigns the patella over the femur is effective in relieving pain and improving function in adults with knee osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Dec 2006
Longer than P75 for not_applicable knee-osteoarthritis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2006
CompletedFirst Posted
Study publicly available on registry
September 28, 2006
CompletedStudy Start
First participant enrolled
December 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedResults Posted
Study results publicly available
June 29, 2017
CompletedJune 29, 2017
May 1, 2017
2.5 years
September 27, 2006
October 13, 2011
May 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Pain on the VIsual Analog Scale (VAS)
The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations, including those with rheumatic diseases. It is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (pain) orientated from the left (best) to the right (worst).The visual analog scale (VAS) pain ranges from 0-100
6 weeks
Change in WOMAC Pain Scale
The WOMAC (Western Ontario and McMaster Osteoarthritis Index) is a widely used self-administered health status measure used in assessing pain, stiffness, and function in patients with OA of the hip or knee. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC pain scale ranges from 0-20. All the items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely). Lower scores indicate lower levels of pain.
6 weeks
Secondary Outcomes (1)
Change in WOMAC Function Scale
6 weeks
Study Arms (2)
Intervention to placebo
OTHERParticipants will wear the patellofemoral realigning knee brace for 6 weeks, followed by the non-aligning knee brace for 6 weeks.
Placebo to intervetion
OTHERParticipants will wear the non-aligning knee brace for 6 weeks, followed by the patellofemoral realigning knee brace for 6 weeks.
Interventions
Knee brace that changes the tracking of the patella over the femur bone
Knee brace that does not change the tracking of the patella over the femur bone
Eligibility Criteria
You may qualify if:
- Knee pain on most days
- Either isolated patellofemoral osteoarthritis or mixed patellofemoral and tibiofemoral osteoarthritis, as based on x-ray
You may not qualify if:
- Bed- or chair-bound, usually uses an ambulation aid to walk (e.g., cane, crutch, or walker), or uses a wheelchair
- Pain emanating more from the back or hip than from the knee, as determined by screening questionnaire
- Low pain score on the visual analog scale (VAS) (less than 4 out of 10)
- Plans to move from the area within 10 months of study screening
- Symptomatic comorbid disease that limits activities more than knee pain does, as determined by screening questionnaire (e.g., congestive heart failure, chronic obstructive pulmonary disease)
- Bilateral total knee replacements or plans for a total knee replacement of the affected knee in the next 6 months
- Morbidly obese (body mass index greater than 35), as brace fitting and prevention of slippage of the brace will be difficult
- Known other causes of arthritis, including rheumatoid arthritis, systemic lupus erythematosus, gout, psoriatic arthritis, and pseudogout
- Skin breakdown at the site where the brace will be applied
- Failure to pass the run-in test, or the brace falls down the leg during the run-in
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Boston University, School of Medicine
Boston, Massachusetts, 02118, United States
New England Baptist Hospital
Boston, Massachusetts, 02120, United States
Related Publications (1)
Hunter DJ, Harvey W, Gross KD, Felson D, McCree P, Li L, Hirko K, Zhang B, Bennell K. A randomized trial of patellofemoral bracing for treatment of patellofemoral osteoarthritis. Osteoarthritis Cartilage. 2011 Jul;19(7):792-800. doi: 10.1016/j.joca.2010.12.010. Epub 2011 Jan 11.
PMID: 21232620RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
There was no control group without a brace for comparison to the intervention because of concerns about unblinding.
Results Point of Contact
- Title
- Director of Clinical Trials
- Organization
- New England Baptist Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
David Hunter, MD
Boston University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2006
First Posted
September 28, 2006
Study Start
December 1, 2006
Primary Completion
June 1, 2009
Study Completion
December 1, 2009
Last Updated
June 29, 2017
Results First Posted
June 29, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share